Prescribed medications for pregnant inpatients were predominantly safe, with 42.26% belonging to FDA pregnancy risk category B and 32.9% to category A, while category X drugs accounted for 0.84%.
What is the prescription pattern and risk categorization of drugs among pregnant inpatients in a tertiary care hospital?
The prescription pattern of drugs among pregnant inpatients was found to be generally safe and rational, with the majority of drugs falling under FDA pregnancy categories A and B.
Absolute Event Rate: 0% vs 0%
Pregnancy is a special physiological condition and managing medical conditions during pregnancy is a challenge due to the teratogenic potential of many drugs. This cross-sectional prospective study was conducted for a period of 6 months to describe the prescription pattern and risk categorization of drugs among pregnant inpatients in a tertiary care hospital. Pregnant inpatients of OBG ward in any trimester who were prescribed with at least one drug were included. Demographic details and list of prescribed drugs were collected from medical records of patients. The drugs prescribed were grouped according to their pharmacological classes and US FDA pregnancy risk classification. Prescription pattern was assessed using WHO core prescribing indicators. A total of 951 drugs comprising 34 different drugs were prescribed for 420 pregnant women. The average number of drugs prescribed per encounter was 2.3 ± 0.9 (SD). Anti- anemic/vitamin and mineral supplements (288, 30.3%), followed by antibiotics (142, 14.93%) and antihypertensive drugs (127, 13.35%) were the most commonly prescribed classes of drugs. As per FDA Drug Risk Category, most of prescribed drugs belonged to category B (42.26%) and category A (32.9%) followed by category C (17%), category D (1.05%) and category X (0.84%). It was found that the overall prescription pattern of drugs among pregnant inpatients was safe and rational since the majority of prescribed drugs fell under category A and B pregnancy. Continuous drug utilization evaluation in this population and interaction of clinical pharmacist with healthcare team is crucial to have rational and safe prescription of drugs among hospitalized pregnant women.
Vafaeerokh et al. (Wed,) reported a other. Prescribed medications for pregnant inpatients were predominantly safe, with 42.26% belonging to FDA pregnancy risk category B and 32.9% to category A, while category X drugs accounted for 0.84%.